bioAffinity Technologies (BIAFW) Return on Capital Employed (2022 - 2026)

bioAffinity Technologies (BIAFW) has 5 years of Return on Capital Employed data on file, last reported at 184.46% in Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 184.46%, up 18399.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 184.46% (up 18399.0% YoY), and the FY2025 annual result was 181.31%, up 2873.0% from the prior year.
• Return on Capital Employed retreated to 184.46% in Q1 2026 per BIAFW's latest filing, from 126.66% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 33.47% in Q4 2022 and troughed at 392.96% in Q2 2025.
• A 5-year average of 169.75% and a median of 151.93% in 2024 frame the typical range for Return on Capital Employed.
• The sharpest annual moves came in 2025 and 2026: Return on Capital Employed slumped 23708 bps in 2025, then soared 18399 bps in 2026.
• A 5-year view of Return on Capital Employed shows it stood at 33.47% in 2022, then tumbled by 242 bps to 114.6% in 2023, then sank by 128 bps to 261.19% in 2024, then jumped by 52 bps to 126.66% in 2025, then tumbled by 46 bps to 184.46% in 2026.
• Business Quant data shows BIAFW's Return on Capital Employed at 184.46% in Q1 2026, 126.66% in Q4 2025, and 179.34% in Q3 2025.